Compare RDI & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDI | MYO |
|---|---|---|
| Founded | 1937 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.6M | 33.2M |
| IPO Year | N/A | 2017 |
| Metric | RDI | MYO |
|---|---|---|
| Price | $1.29 | $0.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 34.5K | ★ 801.8K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $211,292,000.00 | $41,643,203.00 |
| Revenue This Year | $6.85 | $24.69 |
| Revenue Next Year | $10.86 | $20.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.11 | ★ 65.00 |
| 52 Week Low | $1.17 | $0.71 |
| 52 Week High | $1.87 | $7.17 |
| Indicator | RDI | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 55.98 |
| Support Level | $1.23 | $0.71 |
| Resistance Level | $1.33 | $0.95 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 54.67 | 84.63 |
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).